Your Pathology Report Is Data, Not a Verdict: How to Read HER2, Ki-67, Grade, and Margins

None of this means the pathologist got it wrong. It means the report is a set of readings, and readings carry uncertainty. The skill is knowing which lines decide the treatment, and which ones deserve a harder look before anyone acts on them.

The diagnosis line is where the whole plan starts

At the top sits the tumor type: what kind of cell the cancer came from and where. That single line sets the entire treatment path, because a breast cancer, a lymphoma, and a sarcoma are treated by different playbooks. If that line is wrong, everything downstream is aimed at the wrong target.

This is the line most worth a second read, because a tissue call is a human judgment under a microscope, not a machine reading. When outside cases are reviewed by a second pathologist, a meaningful minority get revised. In peer-reviewed second-opinion series the review changes the diagnosis in a small but real share of cases, one large series reporting a major, care-changing revision in about six percent, with higher rates in harder tissue like thyroid, bone and soft tissue, and head and neck. A small percentage, but when it is your case, it is either everything or nothing.

Grade and stage are not the same thing

People collapse these two into one number. They measure completely different things, and confusing them changes what you think you know.

Grade is how abnormal the cancer cells look under the microscope. Well-differentiated cells still resemble normal tissue and tend to behave less aggressively. Undifferentiated cells barely resemble anything, and higher grade usually means faster, more aggressive biology. Grade is about appearance.

Stage is how far the cancer has spread. It is usually written in the TNM system: T for the size and reach of the main tumor, N for whether it reached nearby lymph nodes, M for whether it spread to distant organs. Stage is about geography.

A tumor can be high grade but early stage, or low grade but widespread. Read them as two separate facts, because they answer two separate questions: how mean are the cells, and how far have they traveled.

The receptor and marker lines can flip the whole plan

This is where one line rewrites everything. On a breast cancer report you will see receptor status, and each result opens or closes a door.

• ER and PR (hormone receptors). Positive means the cancer is fed by estrogen or progesterone, which means hormone therapy like tamoxifen or an aromatase inhibitor becomes a real weapon. Negative closes that door. This one word decides whether a whole class of treatment is on the table.
• HER2. About fifteen to twenty percent of breast cancers make too much of the HER2 protein (American Cancer Society). HER2-positive unlocks targeted drugs built specifically for it. But HER2 by immunohistochemistry has a borderline score, 2+, that is officially equivocal and must be re-tested with a FISH test before anyone trusts it. A 2+ that never got reflex FISH is an unfinished line, not an answer.
• Ki-67. This is a proliferation marker: the percentage of tumor cells actively dividing when the sample was taken. Higher means faster-growing biology and can push toward more aggressive treatment. The catch is that there is no single universal cutoff for high. The threshold shifts by cancer type and by lab, somewhere in the range of the teens to thirty percent, so the number matters less than the context it is read in.

The margins line tells you what might still be there

After surgery, the report describes the margins: the edge of the removed tissue. A negative (clear) margin means no cancer cells at the cut edge, so the tumor was likely removed with a buffer around it. A positive (involved) margin means cancer cells reach the edge, which suggests some may have been left behind. A close margin sits near the edge without touching it.

A positive or close margin is not a footnote. It raises the risk the cancer comes back in the same spot, and it often means more surgery or radiation. This is a line to find, read, and ask about directly, not skim past.

How Healz reads a pathology report

Reading a case beats filing one. Here is how Healz does it.

Everything sits in one place. One chat, not ten apps juggling your scans, labs, and reports. The report goes in with the rest of your history.

Frontier AI works the case: the strongest models pointed at your report, reading it as one connected case rather than a page of isolated numbers.

Root-cause technology does the real work. It cross-checks the biomarkers against each other (HER2, Ki-67, grade, stage, margins), so a result that does not fit the rest gets questioned. It flags the unfinished line, a HER2 2+ that never went to FISH, before it is read as settled. And it cross-checks your case against 1M+ others to catch what a single reading misses.

Memory holds the report alongside your other results in the same chat and connects them over time, working together with root-cause so no line is read in isolation.

When you want expert eyes on it, you can bring a board-certified doctor into the same chat for a second opinion.

Five ways to keep your own pathology report honest

1. Read it line by line, not as a verdict. Name the tumor type, grade, stage, margins, and each biomarker separately. Each is a fact you can question on its own.
2. Separate grade from stage every time. One tells you how the cells look, the other tells you how far they went. Never merge them into a single impression.
3. Chase every unfinished biomarker. A HER2 2+ needs FISH. A Ki-67 needs a reference range. An "equivocal" result is a question, not an answer.
4. Treat the tissue call as the highest-stakes line. Because a tissue call decides the entire plan, it is the line most worth a second read, the same discipline that catches a cancer hiding behind the wrong first label.
5. Ask what each line changes. For every result, ask which treatment it opens or closes. If a line does not change anything, learn why. If it changes everything, make sure it is solid.

A pathology report is not a sentence handed down. It is a set of readings, and readings are meant to be questioned and re-read until they hold. Interrogate the page, and one borderline line stops being a missed turn.

Healz was built to question the report, not file it. The wise run Healz.